Covered recipient · General Payments record
SARAH E NEUMANN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$7,862.85
- Reported across 183 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $517.94 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.27 | 7 |
| Janssen Biotech, Inc. | $115.75 | 1 |
| Amgen Inc. | $65.22 | 2 |
| Galderma Laboratories, L.P. | $39.27 | 2 |
| Arcutis Biotherapeutics, Inc. | $37.54 | 2 |
| UCB, Inc. | $21.42 | 1 |
| Biofrontera Inc. | $18.54 | 1 |
| PFIZER INC. | $16.28 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $101.50 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729720 | CMS |
| ABBVIE INC. | $6.94 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729722 | CMS |
| ABBVIE INC. | $16.70 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729724 | CMS |
| ABBVIE INC. | $15.38 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729726 | CMS |
| ABBVIE INC. | $13.10 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729728 | CMS |
| ABBVIE INC. | $12.96 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729730 | CMS |
| ABBVIE INC. | $23.69 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107729732 | CMS |
| Amgen Inc. | $20.10 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117639827 | CMS |
| Amgen Inc. | $45.12 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117639829 | CMS |
| Arcutis Biotherapeutics, Inc. | $15.84 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121120701 | CMS |
| Arcutis Biotherapeutics, Inc. | $21.70 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121120703 | CMS |
| Biofrontera Inc. | $18.54 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095485574 | CMS |
| Galderma Laboratories, L.P. | $17.85 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145378997 | CMS |
| Galderma Laboratories, L.P. | $21.42 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145378999 | CMS |
| Janssen Biotech, Inc. | $115.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078278455 | CMS |
| PFIZER INC. | $16.28 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131723768 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.65 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152274692 | CMS |
| UCB, Inc. | $21.42 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143039083 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.